We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

215 hedge funds and large institutions have $1.15B invested in Editas Medicine in 2018 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 73 increasing their positions, 56 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 25

49% more call options, than puts

Call options by funds: $40.4M | Put options by funds: $27.1M

30% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 56

11% more capital invested

Capital invested by funds: $1.03B → $1.15B (+$119M)

9% more funds holding

Funds holding: 197 → 215 (+18)

1.62% more ownership

Funds ownership: 66.44% → 68.05% (+1.6%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
215
Holders Change
+18
Holders Change %
+9.14%
% of All Funds
4.92%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
46
Increased
73
Reduced
56
Closed
25
Calls
$40.4M
Puts
$27.1M
Net Calls
+$13.2M
Net Calls Change
+$651K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$20.9M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$20.2M
3
AIM
ARK Investment Management
Florida
+$19.9M
4
State Street
State Street
Massachusetts
+$7.14M
5
Morgan Stanley
Morgan Stanley
New York
+$6.59M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$40.7M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$12.1M
3
Millennium Management
Millennium Management
New York
-$10.3M
4
TCIM
TIAA CREF Investment Management
New York
-$7.37M
5
American Century Companies
American Century Companies
Missouri
-$6.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
226
Cubist Systematic Strategies
Connecticut
– -$352K -10,631 Closed
ACI
227
AMP Capital Investors
Australia
– -$336K -10,300 Closed
II
228
Ibex Investors
Colorado
– -$266K -8,015 Closed
PP
229
Paloma Partners
Connecticut
– -$244K -7,360 Closed
MAM
230
Martingale Asset Management
Massachusetts
– -$236K -7,116 Closed
KA
231
Kovack Advisors
Florida
– -$223K -6,730 Closed
EDRH
232
Edmond de Rothschild Holding
Switzerland
– -$50K -1,500 Closed
MCWS
233
McKinley Carter Wealth Services
West Virginia
– -$41K -1,235 Closed
PHK
234
Point72 Hong Kong
Hong Kong
– -$41K -1,232 Closed
SWP
235
Stratos Wealth Partners
Ohio
– -$20K -600 Closed
SIM
236
Sonora Investment Management
Arizona
– -$9.95K -300 Closed
IWM
237
IHT Wealth Management
Illinois
– -$6K -204 Closed
APP
238
Avantax Planning Partners
Iowa
– -$4K -132 Closed
SF
239
Synovus Financial
Georgia
– +$283 +8 New
6 7 8 9
10

EDIT Hedge Fund Activity: Q2 2018 in Review

215 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2018, worth a combined $1.15B — up 11% from $1.03B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new EDIT positions and 25 closed out — a net gain of 21 holders — while 73 added to existing stakes and 56 trimmed.

The largest buyer was BlackRock, adding an estimated $20.9M. The largest seller was Fidelity Investments, cutting an estimated $40.7M.

  • 215 institutional investors held Editas Medicine (EDIT) as of Q2 2018, up from 197 in Q1 2018.
  • Funds reported $1.15B of Editas Medicine stock for Q2 2018, up 11% quarter-over-quarter.
  • 46 funds opened new Editas Medicine positions in Q2 2018 and 25 closed out, a net change of +21 holders.
  • The largest Editas Medicine buyer in Q2 2018 was BlackRock, an estimated $20.9M added.
  • The largest Editas Medicine seller in Q2 2018 was Fidelity Investments, an estimated $40.7M sold.

Based on aggregated 13F filings for Q2 2018.